0000899243-19-005960.txt : 20190304 0000899243-19-005960.hdr.sgml : 20190304 20190304201209 ACCESSION NUMBER: 0000899243-19-005960 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190304 FILED AS OF DATE: 20190304 DATE AS OF CHANGE: 20190304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lawton Alison Frances CENTRAL INDEX KEY: 0001542650 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38822 FILM NUMBER: 19656237 MAIL ADDRESS: STREET 1: 39 ROBINSON ROAD CITY: LEXINGTON STATE: MA ZIP: 02420 FORMER NAME: FORMER CONFORMED NAME: LAWTON ALISON FRANCIS DATE OF NAME CHANGE: 20120216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kaleido Biosciences, Inc. CENTRAL INDEX KEY: 0001751299 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 617-674-9000 MAIL ADDRESS: STREET 1: 18 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-04 0 0001751299 Kaleido Biosciences, Inc. KLDO 0001542650 Lawton Alison Frances C/O KALEIDO BIOSCIENCES, INC. 65 HAYDEN AVE. LEXINGTON MA 02421 1 1 0 0 See Remarks Stock Option (Right to Buy) 15.00 2019-03-04 4 A 0 150000 0.00 A 2029-03-04 Common Stock 150000 150000 D 25% of this option shall vest on January 23, 2020, with the remainder vesting in 12 equal quarterly installments thereafter. President and Chief Executive Officer /s/ Joshua T. Brumm, as Attorney-in-Fact 2019-03-04